“Post-COVID, where the radiology workforce is coming under immense pressure, the need for AI diagnostic assistance could not be greater.” – Prof Chris Hopkins, Consultant Clinical Scientist & Head of TriTech Institute.
Every year in Wales, more than 2500 men are diagnosed with prostate cancer and around 600 men die from the disease.
JivaRDX is a diagnostic aid for prostate cancer that promptly highlights the existence of tumours on MRI scans. The tool enables radiologists to make more informed decisions faster. This reduces misdiagnosis, and therefore unnecessary treatment costs and complications, whilst creating better patient outcomes. Such an AI tool supports the post-COVID requirement for rapid outpatient turnaround.
In this project, Prof Chris Hopkins and Mr Sohail Moosa, working with TriTech Institute, Hywel Dda University Health Board and Jiva.ai, will demonstrate the first innovative deployments of JivaRDX within NHS Wales. This project is being funded by Moondance Cancer Initiative as part of their 2021-2022 Innovation Time Awards.
This article can also be found here.